With all of the advancements in clinical drug development, the CRO-Sponsor relationship has not kept pace. Sponsors say they are frustrated because CROs over-promise, under-deliver and don't offer much in the way of proactive strategic input. CROs complain that they are treated poorly, like a commodity, not a strategic partner.
Download this article to learn:
- How to establish a healthy Sponsor-CRO relationship before your clinical study even gets off the ground.
- How CROs can improve on communication in order to maintain a healthy Sponsor-CRO relationship.
- How Sponsors can improve on communication in order to maintain a healthy Sponsor-CRO relationship.